Cat Number: API1365267271

X-376Ensartinib, X-396

APIs
CAS Number
1365267-27-1
Description
X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins, and ALK point mutation variants. Inhibition of ALK leads to the disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-expressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development.
Molecular Formula
C25H25Cl2FN6O3
Molecular Weight
547.41
Smiles
C[C@@H](OC1CC(NNC1N)C(=O)NC1CCC(CC1)C(=O)N1CCN(C)CC1)C1C(Cl)CCC(F)C1Cl
Purity
0.9872
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 37 mg/mL (67.59 mM)
Relative Density
1.428 (Predicted)
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top